• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低表达水平的 HMBOX1 在高级别浆液性卵巢癌中通过抑制细胞凋亡加速细胞增殖。

Low expression level of HMBOX1 in high-grade serous ovarian cancer accelerates cell proliferation by inhibiting cell apoptosis.

机构信息

Institute of Diagnostics, School of Medicine, Shandong University, Ji'nan, Shandong, China.

Institute of Yantai, China Agricultural University, Beijing, China.

出版信息

Biochem Biophys Res Commun. 2018 Jun 22;501(2):380-386. doi: 10.1016/j.bbrc.2018.04.203. Epub 2018 May 10.

DOI:10.1016/j.bbrc.2018.04.203
PMID:29709478
Abstract

Homeobox-containing 1 (HMBOX1) has been described as a transcription factor involved in the occurrence of some tumors, but its roles in ovarian cancer have never been reported. Here we aimed to investigate the roles of HMBOX1 on high-grade serous ovarian carcinoma (HGSOC). In this present study, HMBOX1 expression was decreased in HGSOC tissues and ovarian cancer cell lines (HO8910 and A2780) compared with ovarian surface epithelial tissues or normal human ovarian surface epithelial cell line (HOSEpiC). The cell proliferation of HOSEpiC was weaker than ovarian cancer cell lines. By altering the expression of HMBOX1 in A2780 and HOSEpiC, we demonstrated that HMBOX1 inhibited the cell proliferation and promoted the cell apoptosis. Furthermore, our study revealed that HMBOX1 downregulated the expression of anti-apoptotic proteins (Bcl-2, Bcl-xL), raised the expression of pro-apoptotic-regulated proteins (Bad, Bax), apoptotic executionior (Caspase3), and P53. In conclusion, HMBOX1 played important roles in occurrence of HGSOC through regulation of proliferation and apoptosis, which implied that HMBOX1 might serve as a new therapeutic target for HGSOC.

摘要

同源盒蛋白 1(HMBOX1)已被描述为一种参与某些肿瘤发生的转录因子,但它在卵巢癌中的作用从未被报道过。在这里,我们旨在研究 HMBOX1 在高级别浆液性卵巢癌(HGSOC)中的作用。在本研究中,与卵巢表面上皮组织或正常人类卵巢表面上皮细胞系(HOSEpiC)相比,HMBOX1 在 HGSOC 组织和卵巢癌细胞系(HO8910 和 A2780)中的表达降低。HOSEpiC 的细胞增殖能力弱于卵巢癌细胞系。通过改变 A2780 和 HOSEpiC 中 HMBOX1 的表达,我们证明 HMBOX1 抑制细胞增殖并促进细胞凋亡。此外,我们的研究表明 HMBOX1 下调了抗凋亡蛋白(Bcl-2、Bcl-xL)的表达,上调了促凋亡调节蛋白(Bad、Bax)、凋亡执行蛋白(Caspase3)和 P53 的表达。总之,HMBOX1 通过调节增殖和凋亡在 HGSOC 的发生中发挥重要作用,这表明 HMBOX1 可能成为 HGSOC 的新治疗靶点。

相似文献

1
Low expression level of HMBOX1 in high-grade serous ovarian cancer accelerates cell proliferation by inhibiting cell apoptosis.低表达水平的 HMBOX1 在高级别浆液性卵巢癌中通过抑制细胞凋亡加速细胞增殖。
Biochem Biophys Res Commun. 2018 Jun 22;501(2):380-386. doi: 10.1016/j.bbrc.2018.04.203. Epub 2018 May 10.
2
ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo.ROR2 通过激活 IRE1α/JNK/CHOP 通路诱导高级别浆液性卵巢癌的细胞凋亡,在体内外研究中均得到证实。
J Transl Med. 2019 Dec 26;17(1):428. doi: 10.1186/s12967-019-02178-x.
3
Inhibition of nuclear factor-kappa B enhances the tumor growth of ovarian cancer cell line derived from a low-grade papillary serous carcinoma in p53-independent pathway.核因子-κB的抑制通过p53非依赖途径增强了源自低级别乳头状浆液性癌的卵巢癌细胞系的肿瘤生长。
BMC Cancer. 2016 Aug 2;16:582. doi: 10.1186/s12885-016-2617-2.
4
Protein kinase C iota promotes glycolysis via PI3K/AKT/mTOR signalling in high grade serous ovarian cancer.蛋白激酶 C 亚型通过 PI3K/AKT/mTOR 信号通路促进高级别浆液性卵巢癌的糖酵解。
Mol Biol Rep. 2024 Sep 14;51(1):983. doi: 10.1007/s11033-024-09918-3.
5
Integrative proteogenomic analyses of human tumours identifies ADNP as a novel oncogenic mediator of cell cycle progression in high-grade serous ovarian cancer with poor prognosis.综合蛋白质基因组学分析人类肿瘤,发现 ADNP 是一种新型致癌基因介质,可促进预后不良的高级别浆液性卵巢癌细胞周期的进展。
EBioMedicine. 2019 Dec;50:191-202. doi: 10.1016/j.ebiom.2019.11.009. Epub 2019 Nov 22.
6
Fascin1 expression in high-grade serous ovarian carcinoma is a prognostic marker and knockdown of fascin1 suppresses the proliferation of ovarian cancer cells.Fascin1 在高级别浆液性卵巢癌中的表达是一个预后标志物,而 Fascin1 的敲低可抑制卵巢癌细胞的增殖。
Int J Oncol. 2014 Mar;44(3):637-46. doi: 10.3892/ijo.2013.2232. Epub 2013 Dec 30.
7
FOXD1 is targeted by miR-30a-5p and miR-200a-5p and suppresses the proliferation of human ovarian carcinoma cells by promoting p21 expression in a p53-independent manner.叉头框蛋白 D1(FOXD1)是 miR-30a-5p 和 miR-200a-5p 的靶标,并通过促进 p21 表达以不依赖 p53 的方式抑制人卵巢癌细胞的增殖。
Int J Oncol. 2018 Jun;52(6):2130-2142. doi: 10.3892/ijo.2018.4359. Epub 2018 Apr 4.
8
Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer.早期组蛋白 H2B 单泛素化的丧失改变了染色质的可及性,并激活了关键的免疫途径,从而促进了卵巢癌的进展。
Cancer Res. 2019 Feb 15;79(4):760-772. doi: 10.1158/0008-5472.CAN-18-2297. Epub 2018 Dec 18.
9
Decreased Eph receptor‑A1 expression is related to grade in ovarian serous carcinoma.Eph 受体 A1 表达降低与卵巢浆液性癌分级有关。
Mol Med Rep. 2018 Apr;17(4):5409-5415. doi: 10.3892/mmr.2018.8528. Epub 2018 Jan 31.
10
The clinical significance and biological function of lncRNA SOCAR in serous ovarian carcinoma.lncRNA SOCAR 在浆液性卵巢癌中的临床意义和生物学功能。
Gene. 2019 Sep 10;713:143969. doi: 10.1016/j.gene.2019.143969. Epub 2019 Jul 9.

引用本文的文献

1
Metabolomic analysis reveals the influence of HMBOX1 on RAW264.7 cells proliferation based on UPLC-MS/MS.基于 UPLC-MS/MS 的代谢组学分析揭示 HMBOX1 对 RAW264.7 细胞增殖的影响。
BMC Genomics. 2023 May 19;24(1):272. doi: 10.1186/s12864-023-09361-x.
2
Transfer RNAs-derived small RNAs and their application potential in multiple diseases.转运RNA衍生的小RNA及其在多种疾病中的应用潜力。
Front Cell Dev Biol. 2022 Aug 22;10:954431. doi: 10.3389/fcell.2022.954431. eCollection 2022.
3
A Liquid-Liquid Phase Separation-Related Gene Signature as Prognostic Biomarker for Epithelial Ovarian Cancer.
一种与液-液相分离相关的基因特征作为上皮性卵巢癌的预后生物标志物
Front Oncol. 2021 Jun 8;11:671892. doi: 10.3389/fonc.2021.671892. eCollection 2021.
4
WTAP promotes osteosarcoma tumorigenesis by repressing HMBOX1 expression in an mA-dependent manner.WTAP 通过依赖 mA 的方式抑制 HMBOX1 表达促进骨肉瘤肿瘤发生。
Cell Death Dis. 2020 Aug 19;11(8):659. doi: 10.1038/s41419-020-02847-6.
5
tRNA-derived fragment tRF-03357 promotes cell proliferation, migration and invasion in high-grade serous ovarian cancer.转运RNA衍生片段tRF-03357促进高级别浆液性卵巢癌的细胞增殖、迁移和侵袭。
Onco Targets Ther. 2019 Aug 16;12:6371-6383. doi: 10.2147/OTT.S206861. eCollection 2019.
6
Hepatocellular carcinoma: Mechanisms of progression and immunotherapy.肝细胞癌:进展机制与免疫治疗。
World J Gastroenterol. 2019 Jul 7;25(25):3151-3167. doi: 10.3748/wjg.v25.i25.3151.